Insulin resistance in the brain is increasingly recognized as a silent driver of cognitive aging — and the question of whether dietary interventions can reverse it carries real weight for millions of adults entering their seventh decade. A rigorously designed crossover trial now offers a mechanistic window into how a single dose of ketone monoester (KME) reshapes both cerebral blood flow dynamics and cognitive speed in older, overweight men.
In this randomized, double-blind, placebo-controlled study involving 18 men averaging 70 years of age and a BMI just above 27, participants consumed either KME at 395 mg per kilogram of body weight or a taste-matched placebo. Blood beta-hydroxybutyrate peaked near 2.9 mmol/L — solidly within nutritional ketosis range — within hours of ingestion. Using pseudo-continuous arterial spin labeling MRI paired with intranasal insulin delivery, researchers mapped how the supplemented brain responded to insulin signaling across discrete regions. Compared to placebo, KME attenuated insulin-induced cerebral blood flow responses across ten distinct brain clusters, including five frontal gyri, several parietal and occipital zones, and two subcortical regions. Critically, this attenuation pattern mirrors what is seen in metabolically healthy individuals — the inverse of the blunted response characteristic of peripheral insulin resistance. A modest but statistically significant improvement in reaction time of approximately 9 milliseconds was also detected, though memory and executive function scores were unchanged.
This trial's use of pCASL-MRI to quantify brain insulin responsiveness is methodologically sophisticated and relatively rare in nutrition research, lending credibility to the mechanistic claims. However, the sample of 18 men is too small to draw population-level conclusions, and the all-male, overweight cohort limits generalizability to women and leaner individuals. The acute single-dose design leaves chronic effects entirely unexplored. Within the broader ketone research landscape, these findings add a plausible neurological mechanism — improved central insulin sensitivity — to the cognitive benefits sometimes attributed to ketosis. That said, a 9-millisecond reaction time improvement, while statistically significant, sits near the threshold of clinical meaningfulness. This work is best characterized as a well-executed mechanistic proof-of-concept that justifies longer, larger trials rather than a practice-changing result.